Literature DB >> 3996156

Esophageal motor function and response to acid perfusion in patients with symptomatic reflux esophagitis.

T W Burns, S G Venturatos.   

Abstract

There is much evidence to suggest that peristaltic function is defective in esophagitis patients and that this defect may contribute to prolonged acid exposure, promoting esophageal mucosal injury. Abnormal peristalsis may also be related to the generation of reflux symptoms. We evaluated primary peristalsis and its relationship to symptoms under basal conditions and during saline and HCl perfusion in 15 symptomatic reflux patients with gross esophagitis and 15 healthy controls. In the basal state, LES pressure (15.3 vs 25.1 mm Hg) and peristaltic amplitude (74.2 vs 104.8 mm Hg) were significantly lower in subjects with gastroesophageal reflux disease (GERD) (P less than 0.05). During HCl perfusion, peristaltic amplitude and duration increased slightly, and peristaltic velocity slightly decreased similarly in both groups. There was no difference in the incidence of nonpropagated, segmental, or swallow-initiated simultaneous contractions, or change in resting intraesophageal pressure during HCl perfusion in control and GERD groups. This study identified abnormal contractile amplitude as a specific defect in the primary peristaltic wave of esophagitis patients but does not support a role for acid-induced motility changes in the generation of symptoms in GERD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3996156     DOI: 10.1007/bf01320258

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Heartburn in late pregnancy. Manometric studies of esophageal motor function.

Authors:  R NAGLER; H M SPIRO
Journal:  J Clin Invest       Date:  1961-06       Impact factor: 14.808

2.  The physiology of heartburn.

Authors:  S G TUTTLE; F RUFIN; A BETTARELLO
Journal:  Ann Intern Med       Date:  1961-08       Impact factor: 25.391

3.  Instrumentation and methods for intraluminal esophageal manometry.

Authors:  W J Dodds
Journal:  Arch Intern Med       Date:  1976-05

4.  Esophageal epithelial response to gastroesophageal reflux. A quantitative study.

Authors:  L F Johnson; T R Demeester; R C Haggitt
Journal:  Am J Dig Dis       Date:  1978-06

5.  Improved infusion system for intraluminal esophageal manometry.

Authors:  R C Arndorfer; J J Stef; W J Dodds; J H Linehan; W J Hogan
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

6.  Controlled production of acute esophagitis. Experimental animal model.

Authors:  H I Goldberg; W J Dodds; C Montgomery; S A Baskin; F F Zboralske
Journal:  Invest Radiol       Date:  1970 Jul-Aug       Impact factor: 6.016

7.  Acid-barium swallows in the radiographic evaluation of clinical esophagitis.

Authors:  M W Donner; M L Silbiger; P Hookman; T R Hendrix
Journal:  Radiology       Date:  1966-08       Impact factor: 11.105

8.  Oesophageal acid clearing: one factor in the production of reflux oesophagitis.

Authors:  C Stanciu; J R Bennett
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

9.  Gastric emptying in patients with gastroesophageal reflux.

Authors:  R W McCallum; D M Berkowitz; E Lerner
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

10.  Clinical and manometric findings in benign peptic strictures of the esophagus.

Authors:  G Ahtaridis; W J Snape; S Cohen
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

View more
  17 in total

1.  Acid perfusion and edrophonium provocation tests in patients with chest pain of undetermined etiology.

Authors:  T Rokkas; A Anggiansah; M McCullagh; W J Owen
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Interaction of gastroesophageal reflux and esophageal motility. Evaluation by ambulatory 24-hour manometry and pH-metry.

Authors:  R Bumm; H Feussner; A H Hölscher; K Jörg; H J Dittler; J R Siewert
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

3.  Modulation of activity in swallowing motor cortex following esophageal acidification: a functional magnetic resonance imaging study.

Authors:  Peter A Paine; Shaheen Hamdy; Xavier Chitnis; Lloyd J Gregory; Vincent Giampietro; Mick Brammer; Steve Williams; Qasim Aziz
Journal:  Dysphagia       Date:  2007-10-23       Impact factor: 3.438

4.  Impaired upper esophageal sphincter reflexes in patients with supraesophageal reflux disease.

Authors:  Arash Babaei; Mukund Venu; Sohrab Rahimi Naini; Jason Gonzaga; Ivan M Lang; Benson T Massey; Sudarshan Jadcherla; Reza Shaker
Journal:  Gastroenterology       Date:  2015-07-17       Impact factor: 22.682

5.  Does healing of esophagitis improve esophageal motor function?

Authors:  V F Eckardt
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

6.  Esophageal mucosal sensitivity: possible links with clinical presentations in patients with erosive esophagitis and laryngopharyngeal reflux.

Authors:  Murat Korkmaz; Erkan Tarhan; Hakan Unal; Haldun Selcuk; Ugur Yilmaz; Levent Ozluoglu
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

7.  Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease.

Authors:  Shih-Chi Ho; Chi-Sen Chang; Chun-Ying Wu; Gran-Hum Chen
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

8.  Pressure events surrounding oesophageal acid reflux episodes and acid clearance in ambulant healthy volunteers.

Authors:  C P Barham; D C Gotley; R Miller; A Mills; D Alderson
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

9.  Effects of intraluminal acidification on oesophageal motor activity.

Authors:  I Bontempo; L Piretta; E Corazziari; F Michetti; F Anzini; A Torsoli
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

10.  Acid perfusion test: does it have a role in the assessment of non cardiac chest pain?

Authors:  E G Hewson; J W Sinclair; C B Dalton; W C Wu; D O Castell; J E Richter
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.